Filing Details

Accession Number:
0001615219-16-000214
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-07-12 15:07:59
Reporting Period:
2016-03-18
Filing Date:
2016-07-12
Accepted Time:
2016-07-12 15:07:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1615219 Flex Pharma Inc. FLKS () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1015816 John Sculley C/O Flex Pharma, Inc.
800 Boylston Street
Boston MA 02199
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-03-18 709 $11.13 709 No 4 P Indirect Held by spouse
Common Stock Acquisiton 2016-03-21 4,000 $12.06 4,709 No 4 P Indirect Held by spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Held by spouse
No 4 P Indirect Held by spouse
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 54,402 Indirect Held by John and Diane Sculley, Tenants in the Entirety
Footnotes
  1. The price in Column 4 is a weighted average purchase price. The prices actually received ranged from $11.09 to $11.16. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
  2. The price in Column 4 is a weighted average purchase price. The prices actually received ranged from $12.06 to $12.10. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.